July 15, 2019 — Featuring dual detectors, the Instadose2 dosimeter addresses international requirements for independent deep [Hp(10)] and shallow [Hp(0.07)] measurements of both photon and beta radiation.

With the capabilities of its predecessor the Instadose+ wireless dosimeter — including on-demand dose results and the ability to wirelessly capture, transmit, measure, analyze and report radiation dose exposure any time, as often as needed — the Instadose2 dosimeter is ideally-suited for high-energy beta-sensitive environments, including: 

• Nuclear medicine/radiotherapy; 

• Interventional radiology; 

• Nuclear power plants; and 

• Research facilities utilizing beta emitting energy sources.

The Instadose smart radiation monitoring platform safeguards against radiation overexposure at facilities across the United States and around the world with:

• Unlimited on-demand and automatic dose reads;

• Daily dose tracking, enabling improved dose controls;

• Automated high dose notifications;

• Online badge reassignments and account access/management; and

• Badge continuity — no more time-consuming collection, mailing, processing and redistribution.

For more information: www.mirion.com